In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In ...

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

Mr. John DeLucia, as a well-respected Regulatory Consultant, is representing Izotropic in its pre-submission interactions with FDA while ensuring the Company's proposals, documentation, filings, and ...

European markets closed higher on Friday, buoyed by robust Chinese growth data and merger talks in the mining sector.

But if Kennedy hopes to target junk food ... Part of Kennedy's new mandate will include overseeing the US Food and Drug Administration (FDA), which has over 18,000 employees.

The massive, multinational corporation announced Monday that it would bend to an executive order, signed by Trump on his ...